AURORA
NAVAJAS GUTIERREZ
Ikertzaileren 2009-2013 tartean
University Medical Center Hamburg-Eppendorf
Hamburgo, AlemaniaUniversity Medical Center Hamburg-Eppendorf-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2023
-
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666
2014
-
Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma
International Journal of Radiation Oncology Biology Physics, Vol. 88, Núm. 2, pp. 292-300
2012
-
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: Results from the randomized multicenter HIT-SIOP PNET 4 trial
Journal of Clinical Oncology, Vol. 30, Núm. 26, pp. 3187-3193